rebound insomnia


Also found in: Wikipedia.

rebound insomnia

An ↑ in insomnia above a baseline, which may appear if long-term hypnotic therapy is abruptly stopped; the effect is greater with short-acting hypnotics. See Insomnia.
References in periodicals archive ?
But I recommend you avoid sleep medications--these may have side effects, such as rebound insomnia, once you stop taking them.
Side effects may include daytime sedation, anterograde amnesia, sleepwalking, sleep-related eating disorder, respiratory depression, and in some cases, rebound insomnia.
Unfortunately, these hypnotic agents cannot induce physiological sleep and in particular their chronic use is related to the development of drug tolerance, rebound insomnia, physical withdrawal symptoms when quitting, sedation, anorexia, anxiety, agitation, tremors, convulsions, and physical and psychological addiction.
Of special interest is Rozerem is not expected to exhibit rebound insomnia, memory impairment, respiratory depression, drug abuse, dependence, and withdrawal as by some of the benzodiazepine receptor agonists.
Treatment Duration: Screening period to determine eligibility and establish baseline sleep parameters, 15 days (nights), followed by 2 days (nights) of placebo to assess rebound insomnia (occurrence of insomnia worse than at baseline after stopping treatment)
A valerian-hops combination reported no serious adverse effects or cases of rebound insomnia.
Unlike with some medications used to treat insomnia, discontinuation of melatonin did not result in rebound insomnia.
Pharmacotherapy is currently the most common treatment modality for insomnia, (5) but long-term use of hypnotics in chronic insomnia can become complicated by drug tolerance, dependence or rebound insomnia.
Nonpharmacologic interventions are the preferred method for treating insomnia in older adults due to risks associated with the use of sedating drugs, including delirium, dependency, rebound insomnia, falls, and hip fractures (Flaherty, 2008).
We found that the patients who had been taking suvorexant for 12 months and were switched to placebo saw their insomnia return, but clinically meaningful withdrawal symptoms and rebound insomnia did not emerge.
Rebound insomnia and withdrawal effects following discontinuation were also evaluated.